xolbe 40 mg comprimido - search results

United States - English - NLM (National Library of Medicine)

albendazole tablet

novadoz pharmaceuticals llc - albendazole (unii: f4216019ln) (albendazole - unii:f4216019ln) - albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, taenia solium . albendazole tablets are indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, echinococcus granulosus . albendazole is contraindicated in patients with known hypersensitivity to the benzimidazole class of compounds or any components of albendazole. risk summary based on findings from animal reproduction studies, albendazole may cause fetal harm when administered to a pregnant woman. however, available human data from a small number of published case series and reports on the use of multiple-dose albendazole in the 1st trimester of pregnancy, and several published studies on single-dose albendazole use later in pregnancy, have not identified any drug-associated risks for major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reprod

United States - English - NLM (National Library of Medicine)

albendazole tablet

pharma packaging solutions, llc dba tjoapack llc - albendazole (unii: f4216019ln) (albendazole - unii:f4216019ln) - albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, taenia solium. albendazole tablets are indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, echinococcus granulosus. albendazole tablets are contraindicated in patients with known hypersensitivity to the benzimidazole class of compounds or any components of albendazole tablets. risk summary based on findings from animal reproduction studies, albendazole tablets may cause fetal harm when administered to a pregnant woman. however, available human data from a small number of published case series and reports on the use of multiple-dose albendazole in the 1 st trimester of pregnancy, and several published studies on single-dose albendazole use later in pregnancy, have not identified any drug-associated risks for major birth defects, miscarriage, or adverse mater

United Kingdom - English - VMD (Veterinary Medicines Directorate)

milbeguard duo 4 mg / 10 mg film coated tablets for small cats and kittens

ceva animal health ltd - milbemycin oxime (a3 and a4), praziquantel - film-coated tablet - anthelmintic - cats

United Kingdom - English - VMD (Veterinary Medicines Directorate)

milbeguard duo 2.5 mg / 25 mg chewable tablets for small dogs and puppies